Answers are grounded in this paper and cite their sources.
Meroterpenoid natural products derived from the 11-membered macrocycle humulene are of great interest due to their potent biological activities and intricate architectures. Whereas molecules derived from the most available (E,E,E)-humulene isomer have been thoroughly investigated, little is known of the chemistry and biological properties of natural products derived from the (E,E,Z)-isomer and derivatives thereof. Herein, we detail the first synthesis of (E,E,Z)-(10S)-hydroxyhumulene through a selective oxidative double-bond isomerization, and using this key building block along with (E,E,Z)-humulene, a suite of complex meroterpenoids was synthesized, including (±)-deoxynoreupenifeldin and neosetophomone B through a chemoenzymatic strategy and pughiinin A through a non-enzymatic route. In addition to gaining synthetic access to a suite of (E,E,Z)-humulene-derived natural products, this work revealed reactivity differences between (E,E,E)-humulene and its (E,E,Z)-isomer. Overall, these efforts culminate in the first total syntheses of three (E,E,Z)-humulene-derived natural products, providing access to this untapped subset of secondary metabolites.
No takes yet. Share an insight, caveat, or question.
Saucedo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: